申请人:——
公开号:US20040063693A1
公开(公告)日:2004-04-01
Compounds of the general formula (I):
1
wherein m, n, R
1
, R
2
, R
3
and R
4
are as described in the specification.
Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament for the treatment of 5-HT
2A
receptor-related disorders or medical conditions.
通式(I)的化合物:其中m,n,R1,R2,R3和R4如说明书所述。还包括包含这些化合物的制药组合物,它们的制备过程,以及使用这些化合物制备治疗5-HT2A受体相关疾病或医疗条件的药物的方法。